CFRA Maintains Hold Opinion On Shares Of Docusign, Inc.

CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We raise our 12-month target price by $5 to $65, applying an EV/sales multiple of 4.2x to our FY 2025 (Jan.) estimate, a slight premium to peers, reflecting its dominant market share position. We raise our FY 2025 EPS estimate by $0.39 to $3.25 and set FY 2026’s at $3.48. DOCU reported Jan-Q operating EPS of $0.76 vs. $0.65, $0.11 above the consensus. Jan-Q revenue increased 8%, with 8% growth in subscription and a 13% increase in billings, driven by solid execution around renewals, especially with large customers. Net dollar retention continued to trend down to 89%, which we expect to continue into FY 2025 but at a moderating pace. While DOCU continues to face a number of headwinds, we are encouraged by Jan-Q results, as well as improving profitability measures. In addition, we continue to believe that international markets continue to present a strong opportunity for expansion for DOCU.

Scroll to Top